Rankings
▼
Calendar
LAB Q1 2016 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena
LAB
Standard BioTools Inc.
$370M
Q1 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$29M
Gross Profit
$17M
58.7% margin
Operating Income
-$19M
-65.1% margin
Net Income
-$20M
-68.6% margin
EPS (Diluted)
$-0.69
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$9M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$354M
Total Liabilities
$255M
Stockholders' Equity
$99M
Cash & Equivalents
$43M
Geographic Segments
UNITED STATES
$13M
45%
Europe
$9M
32%
Asia Pacific
$6M
21%
Other Geographical Countries
$496,000
2%
← FY 2016
All Quarters
Q2 2016 →
